spacer Top Nav Top Nav Top Nav Top Nav Top Nav Top Nav spacer
 

Recent News:

NEW PANEL OF GLOBAL OPINION LEADERS ADVISES CORMEDIX ON TREATMENTS FOR IRON-RELATED DISEASES

04/17/2008

A new Ferroscience Advisory Board has begun providing cutting-edge expertise to CorMedix on developing treatments for iron-related diseases...


More News >>

AFERRIX TO HELP CORMEDIX DEVISE DIAGNOSTIC BIOMARKER TEST

04/17/2008

CorMedix has signed an agreement with Aferrix – a specialized diagnostic company – to help establish an inexpensive, readily available diagnostic biomarker test for urinary labile iron. This new test will support...


More News >>

CorMedix, Inc.

CorMedix, Inc. is a development-stage biopharmaceutical company based in
Summit, New Jersey. We seek to fulfill selected, significant unmet medical needs at the "cardiorenal crossroads" – the therapeutic intersection of cardiovascular disease and kidney (renal) disease. Our therapeutic candidates for cardiorenal disease may be small molecules, biologicals, devices and/or diagnostics (tests) that enable therapy.

Our position emphasizes treating kidney diseases and reducing the commonly associated cardiovascular and metabolic complications – in effect, "treating the kidney to treat the heart."